Works matching IS 20445385 AND DT 2022 AND VI 12 AND IP 1

Results: 24

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.

Published in:

2022

By:

Wang, Huafeng;
Yang, Chang;
Shi, Ting;
Zhang, Yi;
Qian, Jiejing;
Wang, Yungui;
Hu, Yongxian;
Mao, Liping;
Ye, Xiujin;
Liu, Fang;
Xi, Zhenfang;
Shou, Lihong;
Fu, Caiyun;
Naranmandura, Hua;
Jin, Jie;
Zhu, Hong-Hu

Publication type:

Letter

Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia.

Published in:

2022

By:

Kulkarni, Uday P.;
Selvarajan, Sushil;
Lionel, Sharon;
Prakash, Mithun A.;
Palani, Hamenth Kumar;
Balasundaram, Nithya;
Venkataraman, Arvind;
Korula, Anu;
Devasia, Anup J.;
Fouzia, N. A.;
Janet, Nancy Beryl;
Nair, Sukesh Chandran;
Abraham, Aby;
Mani, Thenmozhi;
Lakshmanan, Jeyaseelan;
Arunachalam, Arun Kumar;
Balasubramanian, Poonkuzhali;
George, Biju;
Mathews, Vikram

Publication type:

Letter

Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells.

Published in:

2022

By:

Fiskus, Warren;
Manshouri, Taghi;
Birdwell, Christine;
Mill, Christopher P.;
Masarova, Lucia;
Bose, Prithviraj;
Kadia, Tapan M.;
Daver, Naval;
DiNardo, Courtney D.;
Borthakur, Gautam;
Khoury, Joseph D.;
Verstovsek, Srdan;
Bhalla, Kapil N.

Publication type:

Letter

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6

By:

King, Rebecca L.;
Gupta, Alia;
Kurtin, Paul J.;
Ding, Wei;
Call, Timothy G.;
Rabe, Kari G.;
Kenderian, Saad S.;
Leis, Jose F.;
Wang, Yucai;
Schwager, Susan M.;
Slager, Susan L.;
Kay, Neil. E.;
Koehler, Amber;
Ansell, Stephen M.;
Inwards, David J.;
Habermann, Thomas M.;
Shi, Min;
Hanson, Curtis A.;
Howard, Matthew T.;
Parikh, Sameer A.

Publication type:

Article

Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00615-7

By:

Grimm, Juliane;
Simnica, Donjete;
Jäkel, Nadja;
Paschold, Lisa;
Willscher, Edith;
Schulze, Susann;
Dierks, Christine;
Al-Ali, Haifa Kathrin;
Binder, Mascha

Publication type:

Article

Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00614-8

By:

Jakobsen, Lasse Hjort;
Øvlisen, Andreas Kiesbye;
Severinsen, Marianne Tang;
Bæch, Joachim;
Kragholm, Kristian Hay;
Glimelius, Ingrid;
Gang, Anne Ortved;
Jørgensen, Judit Mészáros;
Frederiksen, Henrik;
Poulsen, Christian Bjørn;
Clausen, Michael Roost;
Pedersen, Per Trøllund;
Pedersen, Robert Schou;
Torp-Pedersen, Christian;
Eloranta, Sandra;
El-Galaly, Tarec Christoffer

Publication type:

Article

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00613-9

By:

Steimlé, Thomas;
Dourthe, Marie-Emilie;
Alcantara, Marion;
Touzart, Aurore;
Simonin, Mathieu;
Mondesir, Johanna;
Lhermitte, Ludovic;
Bond, Jonathan;
Graux, Carlos;
Grardel, Nathalie;
Cayuela, Jean-Michel;
Arnoux, Isabelle;
Gandemer, Virginie;
Balsat, Marie;
Vey, Norbert;
Macintyre, Elizabeth;
Ifrah, Norbert;
Dombret, Hervé;
Petit, Arnaud;
Baruchel, André

Publication type:

Article

Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.

Published in:

2022

By:

He, Rong;
Chiou, Jonathan;
Chiou, Allison;
Chen, Dong;
Chen, Constance P.;
Spethman, Caroline;
Bessonen, Kurt R.;
Oliveira, Jennifer L.;
Nguyen, Phuong L.;
Reichard, Kaaren K.;
Hoyer, James D.;
Althoff, Simon D.;
Roh, Dana J.;
Miller, Mechelle A.;
Yuan, Ji;
Olteanu, Horatiu;
Begna, Kebede;
Tefferi, Ayalew;
Alkhateeb, Hassan;
Patnaik, Mrinal M.

Publication type:

Letter

A simple additive staging system for newly diagnosed multiple myeloma.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00611-x

By:

Abdallah, Nadine H.;
Binder, Moritz;
Rajkumar, S. Vincent;
Greipp, Patricia T.;
Kapoor, Prashant;
Dispenzieri, Angela;
Gertz, Morie A.;
Baughn, Linda B.;
Lacy, Martha Q.;
Hayman, Suzanne R.;
Buadi, Francis K.;
Dingli, David;
Go, Ronald S.;
Hwa, Yi L.;
Fonder, Amie L.;
Hobbs, Miriam A.;
Lin, Yi;
Leung, Nelson;
Kourelis, Taxiarchis;
Warsame, Rahma

Publication type:

Article

Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00610-y

By:

Martello, M.;
Poletti, A.;
Borsi, E.;
Solli, V.;
Dozza, L.;
Barbato, S.;
Zamagni, E.;
Tacchetti, P.;
Pantani, L.;
Mancuso, K.;
Vigliotta, I.;
Rizzello, I.;
Rocchi, S.;
Armuzzi, S.;
Testoni, N.;
Marzocchi, G.;
Martinelli, G.;
Cavo, M.;
Terragna, C.

Publication type:

Article

JAK2 inhibitor persistence in MPN: uncovering a central role of ERK activation.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00609-5

By:

Pandey, Garima;
Kuykendall, Andrew T.;
Reuther, Gary W.

Publication type:

Article

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00608-6

By:

Borgogna, Cinzia;
Bruna, Riccardo;
Griffante, Gloria;
Martuscelli, Licia;
De Andrea, Marco;
Ferrante, Daniela;
Patriarca, Andrea;
Mahmoud, Abdurraouf Mokhtar;
Gaidano, Valentina;
Marchetti, Monia;
Rapezzi, Davide;
Lai, Michele;
Pistello, Mauro;
Ladetto, Marco;
Massaia, Massimo;
Gaidano, Gianluca;
Gariglio, Marisa

Publication type:

Article

Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.

Published in:

2022

By:

Oliveira, Jennifer L.;
Greipp, Patricia T.;
Rangan, Aruna;
Jatoi, Aminah;
Nguyen, Phuong L.

Publication type:

Letter

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00606-8

By:

Begna, K. H.;
Kittur, J.;
Gangat, N.;
Alkhateeb, H.;
Patnaik, M. S.;
Al-Kali, A.;
Elliott, M. A.;
Hogan, W. J.;
Litzow, M. R.;
Pardanani, A.;
Hanson, C. A.;
Ketterling, R. P.;
Tefferi, A.

Publication type:

Article

Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning.

Published in:

2022

By:

Morsink, L. M.;
van Doesum, J.;
Choi, G.;
Hazenberg, C. L. E.;
Biswana, A.;
Meppelink, F.;
Bungener, L. B.;
Lambeck, A. J. A.;
Huls, G.

Publication type:

Letter

Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00604-2

By:

Venugopal, Sangeetha;
Takahashi, Koichi;
Daver, Naval;
Maiti, Abhishek;
Borthakur, Gautam;
Loghavi, Sanam;
Short, Nicholas. J.;
Ohanian, Maro;
Masarova, Lucia;
Issa, Ghayas;
Wang, Xuemei;
Carlos, Bueso-Ramos;
Yilmaz, Musa;
Kadia, Tapan;
Andreeff, Michael;
Ravandi, Farhad;
Konopleva, Marina;
Kantarjian, Hagop M.;
DiNardo, Courtney D.

Publication type:

Article

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00603-3

By:

Fiskus, Warren;
Boettcher, Steffen;
Daver, Naval;
Mill, Christopher P.;
Sasaki, Koji;
Birdwell, Christine E.;
Davis, John A.;
Takahashi, Koichi;
Kadia, Tapan M.;
DiNardo, Courtney D.;
Jin, Qi;
Qi, Yuan;
Su, Xiaoping;
McGeehan, Gerard M.;
Khoury, Joseph D.;
Ebert, Benjamin L.;
Bhalla, Kapil N.

Publication type:

Article

Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study.

Published in:

2022

By:

Mian, Hira;
Sutradhar, Rinku;
Pond, Gregory R.;
Sivapathasundaram, Branavan;
Sussman, Jonathan;
Balitsky, Amaris;
D'Souza, Anita;
Wildes, Tanya M.;
Seow, Hsien

Publication type:

Editorial

Genomic landscape of hyperleukocytic acute myeloid leukemia.

Published in:

2022

By:

Largeaud, Laetitia;
Bertoli, Sarah;
Bérard, Emilie;
Tavitian, Suzanne;
Picard, Muriel;
Dufrechou, Stéphanie;
Prade, Naïs;
Vergez, François;
Rieu, Jean Baptiste;
Luquet, Isabelle;
Sarry, Audrey;
Huguet, Françoise;
Ruiz, Jean;
De Mas, Véronique;
Delabesse, Eric;
Récher, Christian

Publication type:

Letter

Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma.

Published in:

2022

By:

Claveau, Jean-Sébastien;
Savary Bélanger, Sophie;
Ahmad, Imran;
Delisle, Jean-Sébastien;
De Guire, Vincent;
Roy, Jean;
LeBlanc, Richard

Publication type:

Letter

Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.

Published in:

2022

By:

Jain, Arihant;
Nayak, Lingaraj;
Kulkarni, Uday Prakash;
Mehra, Nikita;
Yanamandra, Uday;
Kayal, Smita;
Damodar, Sharat;
John, Joseph M.;
Mehta, Prashant;
Singh, Suvir;
Munot, Pritesh;
Selvarajan, Sushil;
Radhakrishnan, Venkatraman;
Lad, Deepesh;
Kapoor, Rajan;
Dubashi, Biswajit;
Bharath, Ram S.;
Jain, Hasmukh;
Jayachandran, P. K.;
Lakshmanan, Jeyaseelan

Publication type:

Letter

Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x

By:

Wang, Yucai;
Zhou, Shouhao;
Qi, Xinyue;
Yang, Fang;
Maurer, Matthew J.;
Habermann, Thomas M.;
Witzig, Thomas E.;
Wang, Michael L.;
Nowakowski, Grzegorz S.

Publication type:

Article

Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00593-2

By:

Dimopoulos, Meletios A.;
Schjesvold, Fredrik;
Doronin, Vadim;
Vinogradova, Olga;
Quach, Hang;
Leleu, Xavier;
Montes, Yolanda Gonzalez;
Ramasamy, Karthik;
Pompa, Alessandra;
Levin, Mark-David;
Lee, Cindy;
Mellqvist, Ulf Henrik;
Fenk, Roland;
Demarquette, Hélène;
Sati, Hamdi;
Vorog, Alexander;
Labotka, Richard;
Du, Jichang;
Darif, Mohamed;
Kumar, Shaji

Publication type:

Article

Genomic characterization of functional high-risk multiple myeloma patients.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00576-3

By:

Soekojo, Cinnie Yentia;
Chung, Tae-Hoon;
Furqan, Muhammad Shaheryar;
Chng, Wee Joo

Publication type:

Article